MedPage Today recently published an article featuring insight from Rena Conti, Associate Research Director of the Institute for Health System Innovation and Policy. Rena spoke on the need for affordable and accessible COVID-19 treatment, especially with the sheer scale and number of those affected by the pandemic.
Early in the pandemic, the U.S. failed to evaluate repurposed drugs for COVID-19 and “pursued an almost singular focus on vaccines that was very unusual and clearly driven by leadership.
